Medios AG | Mutual Funds

Mutual Funds that own Medios AG

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Baring German Growth Trust
215,000
1.57%
0
0.56%
10/31/2017
Arnica European Opportunity Fund
206,995
1.52%
162,995
6.85%
12/31/2017
109,063
0.8%
0
3.47%
07/31/2018
PWM Vermoegensfondsmandat - DWS - High Conviction Equity (EUR)
80,769
0.59%
0
1.72%
07/31/2018
80,487
0.59%
-24,513
1.04%
07/31/2018
DJE - Absolut
71,000
0.52%
0
0.69%
06/29/2018
Nordea European Smaller Companies Fund
64,600
0.47%
64,600
1.69%
05/31/2018
DekaLux - Mid Cap TF
57,946
0.42%
-557
0.8%
03/29/2018
DWS German Equities Typ O
48,462
0.36%
0
0.23%
07/31/2018
47,500
0.35%
2,500
0.56%
05/31/2018

About Medios

View Profile
Address
Friedrichstrasse 113a
Berlin Berlin 10117
Germany
Employees -
Website http://www.medios.ag
Updated 07/08/2019
Medios AG engages in providing specialty pharmaceutical drugs. These are medicines for patients with rare or chronic diseases such as cancer, HIV and hepatitis, whose personalized therapy is often tedious and cost-intensive due to their individual requirements. It operates through the following segments: Specialty Pharma Trade, Personalized Preparations, and Shared Services.